News
“Prioritise prospective studies and real-world data”
The EAU Research Foundation is uniquely placed to conduct and coordinate important prospective trials in the coming years, its new chairman has told European Urology Today. Prof. Anders Bjartell (Malmö, SE) took over chairmanship of the EAU Research Foundation...
Tumour characteristics and patient profile: Crucial issues in PCa treatment
Despite advances in diagnostic tools and imaging technologies, prostate cancer (PCa) management remains a challenge to many experts due to extensive variability in tumour characteristics and individual patient profiles which complicate the delivery of an optimal treatment plan. “There...
Young Urologists Competition presents fresh insights at BALTIC17
Fresh perspectives on various urological conditions were presented during the highly-anticipated Young Urologists Competition session of the 4th Baltic Meeting in conjunction with the EAU (BALTIC17) held for the second time in Vilnius, Lithuania. Chaired by Professors Bob Djavan (AT) and Michel...
BALTIC17 looks into best practices in uro-oncology
Vilnius welcomed more than 250 participants to the 4th Baltic Meeting (BALTIC17) with the opening session focusing on best and current practices in diagnosing and managing urological cancers particularly the role of biopsy techniques, imaging tools, quality of life...
In Memoriam, Prof. Mostafa Elhilali (1937-2017)
With great sadness, the European Association of Urology announces the death of Prof. Mostafa Elhilali, whilst he was attending the American Association of Genito Urinary Surgeons meeting on Saturday, 29 April. Elhilali was born in Egypt and was awarded...
BALTIC17: Treatment strategies in urological malignancies
The 4th Baltic Meeting in conjunction with the EAU (BALTIC17) which will be held on May 26 and 27 in Vilnius, Lithuania, will examine current challenges in treatment strategies for urological malignancies, stone disease and functional urology, aside from...
Come meet us at AUA2017
The 2017 edition of the Annual Meeting of the American Urological Association will be taking place in Boston, on May 12-16. As a major meeting in the global urological calendar, many of our members will be attending, or in...
eUROGEN is approved by the European Commission
After an extensive assessment, we are pleased to announce that eUROGEN, the European Reference Network (ERN) for rare and complex urogenital diseases and conditions, was officially launched during the 3rd conference on European Reference Networks in Vilnius, Lithuania 9-10...
EAU17: Highlights from the Souvenir Session
Highlights of the five-day 32nd Annual EAU Congress were reported today in the concluding session with members of the EAU Scientific Committee presenting the most noteworthy developments and conclusions in prostate disease, urological cancers, systemic therapy in GU cancer,...
EAU17: Stones: Emerging data and emergency treatment
The 32nd Annual EAU Congress came to a close on Tuesday morning with its final plenary session. For three hours, delegates were updated on emerging trials, differing approaches and specialized lectures on that most urological of topics: stones. The...
EAU17: Inaccurate adverse event reporting may lead to improper treatment of sexually active men with BPH
Reporting on adverse events in clinical trials involving sexually active men with benign prostatic hyperplasia (BPH) are inaccurate and doctors fear this may lead to incorrect estimates of the treatment impact on sexual function. “Spontaneous adverse event reporting including...
EAU17: Plenary Session examines complex neuro-urological cases
The management of complex neuro-urological patients was examined today during the “Functional Urology” session, which was chaired by Prof. Fiona Burkhard (CH) and Prof. Dirk De Ridder (BE). In this Plenary Session, two patient cases were presented by Prof....